IP & Science Product Portfolio

Life Sciences Product Quiz

Over the course of this week (26 30 Nov 2012) a total of 9 questions (3 on Mon, Wed & Fri)
will be posted relating to the information that we have in our products. You will need to login
to the products listed and search for the answers.
The featured products will be Cortellis CI, Cortellis RI, Integrity and Newport.
THE WINNERS:
The answers to all 9 questions must be submitted by the end of the day on Monday 3rd Dec
to Alex Acheson.
All correct & complete entries will be added to a hat and 5 winners will be drawn!
THE PRIZE:
A voucher worth 10 (or equivalent, depending on your country).
MONDAY: CORTELLIS (both Competitive Intelligence & Regulatory Intelligence)

1. GlaxoSmithKline has a drug in phase II development for Alzheimer's disease and

atherosclerosis. What is the name of this drug?
2.

A presentation from Piramal was covered in the second overnight report from
September's ICAAC conference. Find the corresponding drug record and tell us the date
captured in Cortellis that discovery research began?

3. In the Regulatory Intelligence area, search for Regulatory Intelligence Reports published
in March 2012 and filter region to those covering Australia what is the name of this
document?
WEDNESDAY: INTEGRITY
1. A phase III study of Alirocumab in acute coronary syndrome recently got underway. What
is the name of this trial?
2. Search the Experimental Models knowledge area for a model where the species is
chicken and the indication is cancer. What is the Study Type for the model?
3. Find the Acute Radiation Syndrome (ARS) Targetscape (this is in the Targets and
Pathways knowledge area, the only Targetscape under the Poisoning condition). List the
3 intracellular effects of ARS shown in this Targetscape?
FRIDAY: NEWPORT
1. How many active Drug Master Files in the US does Bayer AG have? (Hint: check the
Manufacturing Profile table!)

2. What were the rest of world sales of pregabalin in the 12 months ending June 2012?
3. Veropharm hold one New use type patent, which active ingredient is it for?